Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Abstract Text:

OBJECTIVE: During the last decade cardiovascular risk factors and endothelial dysfunction have been shown to be present early in life in women with Polycystic Ovary Syndrome (PCOS). The aim of the present study was a global assessment of abnormalities in the arterial bed of young women with PCOS by non-invasive, reproducible methods. DESIGN: 27 women with PCOS and 27 control women of comparable age, body mass index and waist-to-hip ratio were studied. Macrovascular function was assessed by flow-mediated dilatation (FMD) on the brachial artery. Nitrate-induced dilatation (NID) was performed to exclude a vascular smooth muscle cells injury. Microvascular function was assessed by venous occlusion plethysmography studying forearm blood flow. Arterial structure was evaluated by ultrasonographic assessment of intima-media thickness (IMT) of the carotid artery. RESULTS: FMD values were lower in women with PCOS compared to controls (PCOS: 3.84+/-0.74% vs. controls: 9.83+/-0.97%, P<0.001), but no difference was observed in NID (PCOS: 16.59+/-1.84% vs. controls: 16.64+/-2.05%, P=0.98) values. The time required for reactive hyperemia to reach peak value, a plethysmography parameter, was longer in PCOS women (PCOS: 20.63+/-4.67 sec vs. controls: 10.38+/-5.11 sec, P=0.02). No difference was observed in the combined IMT among the studied groups (PCOS: 0.49+/-0.01 mm v.s. controls: 0.51+/-0.02 mm, P=0.19). CONCLUSIONS: Using non invasive methodologies endothelial dysfunction in the macrocirculation and early impairment in the microcirculation were demonstrated in young women with PCOS who had normal profile of glycemia, lipidemia and blood pressure, and no evidence of structural arterial impairment.

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Publishing Authors By Initials

For similar cardiovascular diseases: vascular diseases research abstracts see: cardiovascular diseases: vascular diseases research

PUBMED ID PMID:

MEDLINE DATE:

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hormones (Athens, Greece)

VOLUME: 5

Page Numbers: 126-36

Journal Abbreviation: Hormones (Athens)

ISSN: 1109-3099

DAY: 17

MONTH: 03

YEAR: 2008

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101142469

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Keywords Mesh Terms:

KEYWORDS: Vascular Diseases

MESH TERMS: complications

Chemical & Substance for Abstract: Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.

AFFILIATION: Division of Endocrinology, First Department of Medicine, Laiko Hospital.

Country: Greece

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hormones (Athens)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome Related Publications

• Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.
• Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.
• Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
• Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
• Role of obesity and adiposity in polycystic ovary syndrome.
• Serum and seminal plasma ghrelin levels in men with normospermia and dyspermia.
• The knowledge of osteoporosis risk factors in a Greek female population.